Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Estrogen Receptor Antagonist 7 (Compound 13) is a potent antagonist of estrogen receptors (ER), demonstrating antiproliferative effects against breast and ovarian cancer cells, along with anticancer and anti-uterotrophic activities [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 10-14 weeks | $ 1,520.00 | |
50 mg | 10-14 weeks | $ 1,980.00 | |
100 mg | 10-14 weeks | $ 2,500.00 |
Description | Estrogen Receptor Antagonist 7 (Compound 13) is a potent antagonist of estrogen receptors (ER), demonstrating antiproliferative effects against breast and ovarian cancer cells, along with anticancer and anti-uterotrophic activities [1]. |
In vitro | Estrogen receptor antagonist 7 (compound 13) has antiproliferative activity against MCF-7, T-47D and SKOV-3 with IC 50 s of 7.2 μM, 11.71 μM and 29.8 μM, respectively [1]. |
Molecular Weight | 399.4 |
Formula | C23H17N3O4 |
CAS No. | 2889371-04-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Estrogen receptor antagonist 7 2889371-04-2 inhibitor inhibit